C12N 2770/36122
New viral proteins or individual genes, new structural or functional aspects of
Official title: New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
C12N2770/36122 (New viral proteins or individual genes, new structural or functional aspects of) appears on 184 US grants and 234 published applications in this corpus.
Search patents in C12N- Granted patents
- 184
- Published applications
- 234
- Assignees
- 137
- Inventors
- 444
- Latest grant
- 21 Apr 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1991 | 1 | 0 |
| 1992 | 3 | 0 |
| 1993 | 0 | 0 |
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 2 | 0 |
| 1997 | 1 | 0 |
| 1998 | 8 | 0 |
| 1999 | 5 | 0 |
| 2000 | 5 | 0 |
| 2001 | 6 | 1 |
| 2002 | 11 | 5 |
| 2003 | 9 | 12 |
| 2004 | 1 | 10 |
| 2005 | 2 | 4 |
| 2006 | 6 | 7 |
| 2007 | 4 | 3 |
| 2008 | 6 | 9 |
| 2009 | 4 | 5 |
| 2010 | 4 | 10 |
| 2011 | 3 | 6 |
| 2012 | 6 | 2 |
| 2013 | 7 | 5 |
| 2014 | 5 | 9 |
| 2015 | 4 | 6 |
| 2016 | 8 | 8 |
| 2017 | 7 | 5 |
| 2018 | 3 | 7 |
| 2019 | 9 | 11 |
| 2020 | 6 | 11 |
| 2021 | 6 | 12 |
| 2022 | 7 | 15 |
| 2023 | 7 | 15 |
| 2024 | 9 | 23 |
| 2025 | 13 | 17 |
| 2026 | 5 | 16 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Methods and compositions for the detection of host protein cleavage by group IV viral proteases21 Apr 2026US 12,607,633 B2The Government of the United States of America, as represented by the Secretary of the Navy
- Compositions and methods of use of oncolytic virus like vesicles17 Mar 2026US 12,577,585 B2Carogen Corporation
- Method of producing pharmaceutical compositions comprising immunogenic chikungunya virus CHIKV-Δ5nsP33 Mar 2026US 12,564,625 B2Valneva SE
- Fusion antigen of porcine Getah virus, kit, preparation method therefor and application thereof17 Feb 2026US 12,553,895 B2Yangzhou University
- M1 virus mutant and use thereof20 Jan 2026US 12,529,037 B2Guangzhou Virotech Pharmaceutical Co., Ltd.
- Vaccine Adjuvants8 Oct 2026US 2026/0306623 A1Seqirus Inc.
- Dna vaccine for fish against salmonid alphavirus27 Aug 2026US 2026/0248901 A1Intervet Inc.
- Method of producing pharmaceutical compositions comprising immunogenic chikungunya virus chikv-delta5nsp320 Aug 2026US 2026/0240977 A1Valneva SE
- Nanobiosensor and preparation method thereof and virus antibody detection method using same13 Aug 2026US 2026/0235602 A1National Defense Medical University
- Pseudotyped viral particles for targeting tcr-expressing cells6 Aug 2026US 2026/0226500 A1Regeneron Pharmaceuticals, Inc.
Most cited
By later US patents
- Eukaryotic layered vector initiation systems204US 5,814,482 A1998
- Plant viral vectors having heterologous subgenomic promoters for systemic expression of foreign genes185US 5,316,931 ABiosource Genetics Corporation · 1994
- Alphavirus vector constructs167US 5,843,723 AChiron Corporation · 1998
- Alphavirus structural protein expression cassettes152US 5,789,245 AChiron Corporation · 1998
- Eukaryotic layered vector initiation systems126US 6,015,686 AChiron Viagene, Inc. · 2000